<DOC>
	<DOC>NCT01011725</DOC>
	<brief_summary>This study will assess the safety, tolerability, pharmacokinetics, and pharmacodynamic efficacy of MK0773 in healthy postmenopausal women.</brief_summary>
	<brief_title>Safety, Tolerability and Efficacy of MK0773 in Healthy Postmenopausal Women (0773-003)</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<criteria>Subject is a nonsurgical postmenopausal female Subject is neither grossly overweight nor underweight for her height Subject is in good health Subject is willing to avoid excess alcohol and strenuous physical activity during the study Subject agrees to refrain from consuming St. John's Wort, grapefruit or grapefruit juice during the study Subject has significant drug allergies Subject has donated blood or taken an investigational drug in another clinical trial within the last 4 weeks Subject is a regular user or past abuser of any illicit drug (including alcohol) Subject drinks excessive amounts of caffeinated beverages Subject has a history of cancer</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>